Substituted anilinic piperidines as MCH selective antagonists

A compound having the structure:

• wherein W is
• wherein R1 is hydrogen, straight chained or branched C1–C7 alky, aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more —F, —Cl, —Br, —CN, —NO2, —OCH3, —CO2CH3, —CF3, phenyl, straight chained or branched C1–C7 alkyl;
• wherein R2 is straight-chained or branched C3–C4 alkyl or cyclopropyl;
• wherein A is —H, —F, —Cl, —Br, —CN, —NO2, —COR1, —CO2R1, straight chained or branched C1–C7 alkyl, monofluoroalkyl or polyfluoroalkyl or phenyl;
• wherein each B is independently —H, —F, —Cl, —Br, —I, —CN, —NO2, —COR1, —CO2R1, —OCH3, —OCF3, —CF3, straight chained or branched C1–C7 alkyl, monofluoroalkyl or polyfluoroalkyl or aryl, phenoxy or benzyloxy, wherein the aryl, phenoxy or benzyloxy is optionally substituted with one or more —F, —Cl, —Br, —CN, —NO2, —COR1, —CO2R1, —OCH3, —OCF3, —CF3 or straight chained or branched C1–C7 alkyl.